Nottingham Advisors’s Johnson & Johnson JNJ Stock Holding History

Nottingham Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Hold	1,051	–	–	0.03%	105
2026 Q1	$257K	Hold	1,051	–	–	0.03%	105
2025 Q4	$218K	Sell	1,051 -460	-30%	-$91K	0.03%	105
2025 Q3	$280K	Hold	1,511	–	–	0.04%	90
2025 Q2	$231K	Sell	1,511 -675	-31%	-$104K	0.03%	100
2025 Q1	$363K	Sell	2,186 -1,529	-41%	-$239K	0.06%	92
2024 Q4	$537K	Sell	3,715 -773	-17%	-$120K	0.07%	87
2024 Q3	$727K	Sell	4,488 -2,000	-31%	-$319K	0.08%	81
2024 Q2	$948K	Buy	6,488 +1,915	+42%	+$285K	0.11%	69
2024 Q1	$723K	Sell	4,573 -67	-1%	-$10.7K	0.09%	74
2023 Q4	$727K	Buy	4,640 +117	+3%	+$17.9K	0.1%	72
2023 Q3	$704K	Sell	4,523 -280	-6%	-$46.2K	0.11%	69
2023 Q2	$795K	Hold	4,803	–	–	0.1%	69
2023 Q1	$744K	Sell	4,803 -271	-5%	-$43.8K	0.1%	74
2022 Q4	$896K	Sell	5,074 -210	-4%	-$36.3K	0.12%	68
2022 Q3	$863K	Sell	5,284 -51	-1%	-$8.63K	0.12%	62
2022 Q2	$947K	Sell	5,335 -50	-0.9%	-$8.91K	0.13%	59
2022 Q1	$954K	Sell	5,385 -26	-0.5%	-$4.42K	0.11%	66
2021 Q4	$926K	Buy	5,411 +15	+0.3%	+$2.46K	0.1%	71
2021 Q3	$872K	Sell	5,396 -500	-8%	-$85.3K	0.09%	73
2021 Q2	$971K	Buy	5,896 +413	+8%	+$68.4K	0.11%	72
2021 Q1	$901K	Sell	5,483 -90	-2%	-$14.6K	0.1%	72
2020 Q4	$877K	Sell	5,573 -78	-1%	-$11.5K	0.13%	71
2020 Q3	$841K	Buy	5,651 +1,144	+25%	+$169K	0.11%	71
2020 Q2	$644	Buy	4,507 +500	+12%	+$72.9K	0.04%	77
2020 Q1	$525K	Buy	4,007 +250	+7%	+$35.5K	0.08%	77
2019 Q4	$548K	Sell	3,757 -1,798	-32%	-$244K	0.07%	74
2019 Q3	$719K	Buy	5,555 +600	+12%	+$79K	0.09%	66
2019 Q2	$690K	Buy	4,955 +90	+2%	+$12.5K	0.1%	66
2019 Q1	$680K	Sell	4,865 -185	-4%	-$24.8K	0.1%	64
2018 Q4	$698K	Hold	5,050	–	–	0.11%	59
2018 Q3	$698K	Buy	5,050 +1,236	+32%	+$164K	0.11%	61
2018 Q2	$489K	Sell	3,814 -1,610	-30%	-$201K	0.08%	65
2018 Q1	$695K	Sell	5,424 -2,212	-29%	-$299K	0.12%	50
2017 Q4	$1.07M	Sell	7,636 -962	-11%	-$134K	0.15%	51
2017 Q3	$1.12M	Buy	8,598 +1,957	+29%	+$259K	0.16%	50
2017 Q2	$879K	Sell	6,641 -150	-2%	-$19.1K	0.13%	60
2017 Q1	$846K	Buy	6,791 +800	+13%	+$95.6K	0.13%	57
2016 Q4	$690K	Buy	5,991 +600	+11%	+$69.3K	0.12%	60
2016 Q3	$637K	Sell	5,391 -50	-0.9%	-$6.07K	0.11%	59
2016 Q2	$660K	Sell	5,441 -200	-4%	-$22.7K	0.12%	54
2016 Q1	$579K	Hold	5,641	–	–	0.11%	61
2015 Q4	$579K	Buy	5,641 +508	+10%	+$51.1K	0.11%	61
2015 Q3	$479K	Sell	5,133 -200	-4%	-$19.3K	0.09%	66
2015 Q2	$520K	Buy	5,333 +115	+2%	+$11.5K	0.09%	69
2015 Q1	$525K	Buy	5,218 +1,435	+38%	+$146K	0.09%	68
2014 Q4	$394K	Buy	3,783 +337	+10%	+$35.5K	0.1%	63
2014 Q3	$367K	Buy	3,446 +325	+10%	+$33.7K	0.13%	40
2014 Q2	$326K	Buy	3,121 +225	+8%	+$22.7K	0.12%	41
2014 Q1	$284K	Sell	2,896 -699	-19%	-$64.8K	0.11%	40
2013 Q4	$329K	Hold	3,595	–	–	0.11%	42
2013 Q3	$311K	Hold	3,595	–	–	0.11%	42
2013 Q2	$308K	Buy	+3,595	New	+$305K	0.13%	38

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nottingham Advisors's JNJ Position: Q2 2026 in Review

Nottingham Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,051 shares worth $262K. The position accounts for 0.03% of the portfolio, ranked #105.

Nottingham Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.12M in Q3 2017. 2,377 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Nottingham Advisors held 1,051 shares of Johnson & Johnson worth $262K as of Q2 2026.
Nottingham Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.03% of Nottingham Advisors's portfolio in Q2 2026, its #105 holding.
Nottingham Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
Nottingham Advisors's Johnson & Johnson position peaked at $1.12M in Q3 2017.
2,377 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nottingham Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.